New Delhi; , Sep 10: AstraZeneca announced a temporary halt late on Tuesday to the global trials of the Covid-19 vaccine candidate developed by the University of Oxford due to a serious adverse event in the United Kingdom, recruitment of participants in India had already been put on hold last week after the first 100 participants were administered the shot.
The adverse event seen in the UK case has not been noted in any of the Indian participants so far.
|